Most Recent
Banksia silk wants to cross-examine prosecutor’s witnesses in criminal case
Disgraced barrister Norman O'Bryan will seek to grill two witnesses for the prosecution in a criminal case accusing the former silk of attempting to fraudulently obtain $1.3 million in fees.
Construction PRO
Maddocks reps Simonds Group in $10M purchase of Dennis Family Homes
Law firm Maddocks has advised Simonds Group on its $10 million pick-up of Dennis Family Homes, an acquisition expected to generate $200 million in additional revenue for the homebuilder next year.
Law firms team up to file competing Google ad tech class action
Two law firms have joined forces in a second class action on behalf of publishers alleging Google misused its dominance in the digital advertising market.
Telstra cops $394,000 penalty for NBN speed testing failures
Telstra has paid a $394,380 penalty for shirking its obligation to check internet speeds when migrating customers to the NBN.
Construction PRO
Lendlease wins appeal over Circular Quay land valuation
Lendlease's appeal of the NSW Valuer General's land value determinations of luxury residential tower One Circular Quay has prevailed.
Construction PRO
Arnold Bloch Leibler advises Merricks on sale of Melbourne Place Hotel
Advised by Arnold Bloch Leibler, fund manager Merricks Capital has sold the $155M Melbourne Place Hotel after it opened in the Paris end of the CBD in December.
Construction PRO
Ashurst loses real estate partner to Clayton Utz
Real estate lawyer Vicki Aron has joined Clayton Utz's Sydney office as a partner after seven years at Ashurst.
Jones Day grows corporate practice with partners from Hogan Lovells
Global law firm Jones Day has recruited two corporate partners from rival Hogan Lovells to join its transactions team in Sydney.
Construction PRO
Drivas plans for add-on to Parramatta Square heritage site refused again
Property developer Drivas has lost its court fight over plans for a nine-storey tower atop the heritage-listed Murrays Building in Parramatta's Centenary Square.
Novartis appeals IP win for Pharmacor over blood pressure drug
Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.